SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cymeed who wrote (422)12/13/1997 11:30:00 AM
From: John McCarthy  Read Replies (1) of 887
 
Cymeed -

<<I would not be totally surprised to see Depo tanks too on Dec 19. This all depends on the thinking of the crowd, which is totally unpredicatable.>>

If you bought into DEPO for the bounce, I would be afraid.

If South Korea tanks next week, i.e. the WON goes to
a *billion* for the dollar, all stocks w/o earnings will get
slammed. And those with earnings - will get slammed.

No one will care about earnings *prospects*.

Things will be in chaos until new *safe* market sectors are
defined. High tech and biotech ain't gonna cut it, at least
initially.

That out of the way, there is no connection between
GLIA and DEPO. Or DEPO and any other drug up
for review.

DEPO delivers a chemo drug in a very efficient manner
which (a) lets someone live a little bit longer than
otherwise - yes - they STILL die using DC (b)
or, potentially, DEPO (DC) saves someones life who
otherwise would have died because DC was introduced
early in the program.

As doctors climbed the learning curve, they will reach
for *the bottle* sooner, both on and off-label. They
want to win - they want their patient to win.

DEPO gives them a chance for winning.

This is why the prospect for DEPO is so large.

Look at it this way, people are already dead who should
not be, because this drug is not freely available.

But none of these assumptions, on may part, will be reflected
in the price of DEPO until we are near the FINAL, FINAL,
SUPER FINAL FDA review. Whenever that is.

Regards,

John McCarthy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext